Position in IQV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$22,677,265
+$2,221,675 QoQ
Shares Held
117,365
-2.2% QoQ
Ownership
0.070%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#140
of 1,077 holders
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in IQV Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Cetera Investment Advisers holds $179,401,377 across 25 Diagnostics & Research names. IQV ranks #3 (12.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
109,972 | $55,135,561 | |
| 2 | DHR |
Danaher Corp /De/
|
139,533 | $26,578,245 | |
| 3 | IQV |
Iqvia Holdings Inc.
This page
|
117,365 | $22,677,265 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
22,840 | $12,023,889 | |
| 5 | LH |
Labcorp Holdings Inc.
|
32,320 | $9,049,600 | |
| 6 | DGX |
Quest Diagnostics Inc
|
39,616 | $8,396,611 | |
| 7 | NTRA |
Natera, Inc.
|
27,675 | $7,512,378 | |
| 8 | A |
Agilent Technologies, Inc.
|
48,741 | $6,474,267 |
All Filings in IQV
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,677,265 | 117,365 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $20,455,590 | 119,946 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $25,342,620 | 112,429 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $21,336,719 | 112,334 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $15,773,655 | 100,093 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $12,813,660 | 72,681 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $12,607,492 | 64,157 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $17,279,378 | 72,918 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $15,139,526 | 71,602 | Shares | Sole | 2024-08-22 | |
| 2024-03-31 | $17,532,863 | 69,330 | Shares | Sole | 2024-05-24 | |
| 2023-12-31 | $2,053,497 | 8,875 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,830,562 | 9,304 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,049,902 | 9,120 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,671,471 | 8,404 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $823,043 | 4,017 | Shares | Sole | 2023-02-14 | |
| 2022-06-30 | $240,207 | 1,107 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $351,207 | 1,519 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $464,684 | 1,647 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $367,214 | 1,533 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $443,930 | 1,832 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $210,522 | 1,090 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $455,450 | 2,542 | Shares | Sole | 2021-02-17 | |
| No filing history on record for this holder in this stock. | ||||||